Medicare Enrolled
Dr. Rama Balaraman, M.D.
Hematology & Oncology · Ocala, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Balaraman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Balaraman?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Balaraman
Dr. Rama Balaraman is a hematology & oncology specialist in Ocala, FL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Balaraman performed 170,639 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Balaraman received a total of $95,697 from 105 pharmaceutical and/or device companies across 1217 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Balaraman is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 3% volume in FL
$95,697 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 88274 | Clear | January 31, 2027 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary — 2023
Medicare Utilization ↗170,639
Medicare services
Top 3% in FL for hematology & oncology
Not available
Unique patients (not deduplicated)
$18
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Darbepoetin injection (Aranesp) for anemia An injection of darbepoetin alfa used for non-end-stage renal disease purposes. |
33,500 | $2 | $21 |
| Pembrolizumab injection (Keytruda) | 32,400 | $43 | $146 |
| Filgrastim injection (Zarxio) for white blood cells An injection of the biosimilar medication filgrastim-sndz (Zarxio) with a dosage of 1 microgram. |
27,660 | $0 | $2 |
| Denosumab injection (Prolia/Xgeva) | 13,380 | $18 | $70 |
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
9,450 | $0 | $3 |
| Daratumumab injection (Darzalex) An injection containing daratumumab and hyaluronidase-fihj administered under the skin. |
9,180 | $38 | $136 |
| Iron infusion (Monoferric) | 7,300 | $16 | $76 |
| Immune globulin infusion (Octagam) This procedure involves the administration of immune globulin medication directly into a vein. It is provided in a non-lyophilized liquid form. |
6,894 | $33 | $251 |
| Anti-nausea injection (aprepitant) | 4,030 | $1 | $9 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
3,362 | $8 | $35 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
3,198 | $8 | $19 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
2,227 | $10 | $62 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
1,462 | $0 | $1 |
| Lactate dehydrogenase (LDH) level test A blood test that measures the amount of lactate dehydrogenase, an enzyme found in many body tissues. It helps assess tissue damage or disease. |
1,378 | $6 | $30 |
| Epoetin alfa injection (Retacrit) for anemia An injection of a biosimilar form of epoetin alfa used for non-end-stage renal disease purposes. The dose administered is 1000 units. |
1,010 | $6 | $30 |
| Iron binding capacity test A blood test that measures the amount of iron in the blood and the blood's ability to bind and transport iron. |
994 | $9 | $34 |
| Iron level test | 993 | $6 | $26 |
| Ferritin level test (iron stores) A blood test that measures the level of ferritin, a protein that stores iron in the body. |
985 | $13 | $58 |
| Injection, fulvestrant, 25 mg | 820 | $9 | $262 |
| Anti-nausea injection (Aloxi/palonosetron) | 780 | $1 | $122 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
721 | $95 | $224 |
| Injection, granisetron hydrochloride, 100 mcg | 700 | $0 | $25 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
584 | $10 | $93 |
| Vitamin B-12 level test A blood test that measures the amount of vitamin B-12 in your body. |
543 | $15 | $74 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
483 | $12 | $105 |
| Folic acid level test A blood test that measures the amount of folic acid in the serum. |
456 | $14 | $71 |
| Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 | 423 | $20 | $124 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
370 | $99 | $686 |
| Immunoassay substance measurement A laboratory test that uses immunoassay techniques to measure the level of a specific substance in a sample. |
352 | $17 | $181 |
| Nephelometry test A laboratory test that uses light scattering to measure the concentration of specific substances in a sample. |
352 | $13 | $176 |
| Platelet-associated immunoglobulin antibody test A laboratory test that identifies antibodies attached to platelets. It measures the amount of immunoglobulin associated with the patient's platelets. |
297 | $12 | $155 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
297 | $58 | $148 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
270 | $47 | $304 |
| Thyroid stimulating hormone (TSH) test A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function. |
240 | $16 | $78 |
| Carboplatin chemotherapy injection, 50 mg Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection. |
196 | $2 | $300 |
| Pegfilgrastim-apgf injection An injection of pegfilgrastim-apgf, a biosimilar medication. The dose specified is 0.5 mg. |
192 | $89 | $879 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
175 | $16 | $97 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
175 | $55 | $205 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
173 | $1 | $19 |
| Adrenocorticotropic hormone (ACTH) level test A blood test that measures the amount of adrenocorticotropic hormone in your body. |
158 | $38 | $166 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
156 | $7 | $462 |
| Immunoglobulin light chain measurement A blood test that measures the levels of immunoglobulin light chains, which are proteins produced by plasma cells. |
144 | $17 | $60 |
| Free thyroxine (T4) test A blood test that measures the level of free thyroxine, a thyroid hormone, in the bloodstream. |
138 | $9 | $63 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
133 | $1 | $7 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
116 | $25 | $249 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
106 | $96 | $232 |
| CT scan of chest with contrast A computed tomography scan of the chest using a contrast dye to enhance the visibility of internal structures. |
96 | $89 | $1,005 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
95 | $50 | $334 |
| Normal saline infusion, 500 ml Administration of sterile normal saline solution through an intravenous line. This procedure involves the infusion of a 500 ml unit of the solution. |
94 | $1 | $19 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
83 | $64 | $157 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
81 | $25 | $141 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
81 | $2 | $19 |
| Uric acid level test A blood test that measures the level of uric acid in your body. Uric acid is a waste product formed when the body breaks down purines. |
79 | $4 | $24 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
76 | $22 | $156 |
| CT scan of abdomen and pelvis with contrast A CT scan that uses dye to create detailed images of the abdomen and pelvis. This imaging test helps doctors examine internal organs and structures in these areas. |
74 | $212 | $1,400 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 73 | $408 | $638 |
| Basic metabolic blood panel A blood test that measures a group of basic chemicals, including total calcium levels. |
70 | $8 | $48 |
| Nuclear medicine scan from skull base to mid-thigh with CT A nuclear medicine imaging study covering the area from the base of the skull to the middle of the thighs, performed alongside a CT scan. |
68 | $1,206 | $4,120 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
67 | $21 | $152 |
| PSA test (prostate cancer screening) | 64 | $18 | $91 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
63 | $10 | $73 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
61 | $139 | $301 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
61 | $140 | $412 |
| New patient office visit, complex (60-74 min) | 50 | $170 | $432 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
49 | $2 | $16 |
| CT scan of chest, without contrast A computed tomography scan of the chest area that uses X-rays to create detailed images without the use of contrast dye. |
44 | $72 | $861 |
| Intravenous push injection of new drug or substance A healthcare provider injects a new medication or substance directly into a vein using a push technique. |
42 | $43 | $281 |
| Carcinoembryonic antigen (CEA) level test A blood test that measures the level of carcinoembryonic antigen (CEA) protein. This test is used to monitor certain types of cancer. |
35 | $19 | $96 |
| CT scan of abdomen and pelvis, without contrast A computed tomography scan that creates detailed images of the abdominal and pelvic organs. The procedure is performed without the use of intravenous contrast dye. |
33 | $124 | $892 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
27 | $1 | $9 |
| Blood sample collection from implanted device This procedure involves drawing a blood sample directly from a medical device that has been surgically placed in the body. |
25 | $18 | $64 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
24 | $19 | $111 |
| Concurrent intravenous infusion Administration of medication or fluid into a vein for therapy, prevention, or diagnosis while another infusion is being given. |
22 | $15 | $91 |
| Beta-2 microglobulin level test A blood test that measures the level of beta-2 microglobulin, a protein produced by cells in the body. |
20 | $16 | $93 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
16 | $121 | $343 |
| Bone marrow biopsy and aspiration A procedure to remove a small sample of bone marrow and liquid for laboratory testing. The sample is analyzed to help diagnose various medical conditions. |
13 | $137 | $523 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
9.1% high complexity
80.3% medium
10.6% routine
Industry Payment Transparency
Open Payments through 2024 ↗$95,697
Total received (2018-2024)
Avg $13,671/year across 7 years
Top 10% in FL for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
105
Companies
1,217
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$5,717
2023
$14,865
2022
$11,350
2021
$17,030
2020
$20,058
2019
$10,610
2018
$16,068
Payments by company (2024)
Genentech USA, Inc.
$2,287
PFIZER INC.
$289
AstraZeneca Pharmaceuticals LP
$278
Merck Sharp & Dohme LLC
$263
Novartis Pharmaceuticals Corporation
$183
Janssen Biotech, Inc.
$177
Daiichi Sankyo Inc.
$170
Eisai Inc.
$153
Amgen Inc.
$150
Genmab U.S., Inc.
$127
E.R. Squibb & Sons, L.L.C.
$110
Novocure Inc.
$108
Takeda Pharmaceuticals U.S.A., Inc.
$93
JAZZ PHARMACEUTICALS INC.
$90
Celgene Corporation
$85
ABBVIE INC.
$83
GENZYME CORPORATION
$71
Coherus Biosciences Inc.
$65
Regeneron Healthcare Solutions, Inc.
$62
TAIHO ONCOLOGY, INC.
$61
Gilead Sciences, Inc.
$60
Lilly USA, LLC
$58
SOBI, INC
$57
BeiGene USA, Inc.
$49
Bayer Healthcare Pharmaceuticals Inc.
$49
ARRAY BIOPHARMA INC
$45
Astellas Pharma US Inc
$44
SERVIER PHARMACEUTICALS LLC
$33
Mirati Therapeutics, Inc.
$32
Apellis Pharmaceuticals, Inc.
$29
Incyte Corporation
$28
Rigel Pharmaceuticals, Inc.
$27
SUN PHARMACEUTICAL INDUSTRIES INC.
$27
CSL Behring
$26
Fennec Pharmaceuticals, Inc.
$24
Tempus AI, Inc
$23
Boehringer Ingelheim Pharmaceuticals, Inc.
$23
EMD Serono, Inc.
$21
Alexion Pharmaceuticals, Inc.
$21
Pharmacosmos Therapeutics Inc.
$20
PharmaEssentia USA Corporation
$20
TerSera Therapeutics LLC
$19
Geron Corporation
$19
GlaxoSmithKline, LLC.
$16
Secura Bio, Inc.
$16
Kyowa Kirin, Inc.
$14
PUMA BIOTECHNOLOGY, INC.
$14
Top 3 companies account for 49.9% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$13,399
AstraZeneca Pharmaceuticals LP
$8,623
Genentech, Inc.
$7,963
PFIZER INC.
$7,933
Foundation Medicine, Inc.
$5,390
E.R. Squibb & Sons, L.L.C.
$4,074
Kite Pharma, Inc.
$3,731
Ipsen Biopharmaceuticals, Inc
$3,654
BeiGene USA, Inc.
$3,457
Pharmacosmos Therapeutics Inc.
$3,216
Genentech USA, Inc.
$3,088
Puma Biotechnology, Inc.
$3,036
Astellas Pharma US Inc
$2,648
Fresenius Kabi USA, LLC
$2,550
Lilly USA, LLC
$2,516
Boehringer Ingelheim Pharmaceuticals, Inc.
$2,050
G1 Therapeutics, Inc.
$1,577
MorphoSys, US Inc.
$1,554
Janssen Biotech, Inc.
$1,251
Amgen Inc.
$1,167
Alexion Pharmaceuticals, Inc.
$1,151
Seagen Inc.
$671
Daiichi Sankyo Inc.
$640
Rigel Pharmaceuticals, Inc.
$544
Merck Sharp & Dohme LLC
$522
Celltrion USA Inc.
$449
Incyte Corporation
$436
Eisai Inc.
$417
JAZZ PHARMACEUTICALS INC.
$409
Celgene Corporation
$405
GENZYME CORPORATION
$361
Seattle Genetics, Inc.
$361
Merck Sharp & Dohme Corporation
$351
GlaxoSmithKline, LLC.
$310
EISAI INC.
$308
Genmab U.S., Inc.
$249
Octapharma USA, Inc.
$246
Takeda Pharmaceuticals U.S.A., Inc.
$244
Gilead Sciences, Inc.
$244
Pharmacyclics LLC, An AbbVie Company
$230
Bayer HealthCare Pharmaceuticals Inc.
$216
Heron Therapeutics, Inc.
$185
NOVARTIS PHARMACEUTICALS CORPORATION
$167
Exelixis Inc.
$154
Regeneron Healthcare Solutions, Inc.
$143
Dova Pharmaceuticals
$128
Bayer Healthcare Pharmaceuticals Inc.
$127
EMD Serono, Inc.
$125
Stryker Corporation
$125
Apellis Pharmaceuticals, Inc.
$122
ARRAY BIOPHARMA INC
$121
Karyopharm Therapeutics Inc.
$117
Kyowa Kirin, Inc.
$110
Novocure Inc.
$108
TAIHO ONCOLOGY, INC.
$105
Agios Pharmaceuticals, Inc.
$105
ABBVIE INC.
$102
Coherus Biosciences Inc.
$97
TerSera Therapeutics LLC
$96
Sun Pharmaceutical Industries Inc.
$95
Taiho Oncology, Inc.
$90
SOBI, INC
$89
CSL Behring
$89
PUMA BIOTECHNOLOGY, INC.
$89
Janssen Scientific Affairs, LLC
$77
Clovis Oncology, Inc.
$71
Stemline Therapeutics Inc.
$66
Pharmacyclics LLC, an AbbVie Company
$66
TG THERAPEUTICS, INC.
$65
SERVIER PHARMACEUTICALS LLC
$54
Servier Pharmaceuticals LLC
$53
Epizyme, Inc.,
$52
Astellas Pharma Global Development
$48
Mirati Therapeutics, Inc.
$47
TG Therapeutics, Inc.
$46
Lexicon Pharmaceuticals, Inc.
$45
PharmaEssentia USA Corporation
$43
GE HealthCare
$39
Array BioPharma Inc.
$38
PORTOLA PHARMACEUTICALS, INC.
$35
Horizon Therapeutics plc
$32
Blueprint Medicines Corporation
$31
Global Blood Therapeutics, Inc.
$30
Emmaus Medical, Inc.
$29
MEDIVATION FIELD SOLUTIONS LLC
$27
SUN PHARMACEUTICAL INDUSTRIES INC.
$27
Secura Bio, Inc.
$26
Fennec Pharmaceuticals, Inc.
$24
RECORDATI_RARE_DISEASES_INC.
$24
Tempus AI, Inc
$23
ImmunoGen, Inc.
$23
Teva Pharmaceuticals USA, Inc.
$22
ADC Therapeutics America, Inc.
$21
Medtronic, Inc.
$20
Advanced Accelerator Applications
$19
Geron Corporation
$19
CTI BioPharma Corp.
$17
Alnylam Pharmaceuticals Inc.
$17
Blue Earth Diagnostics Limited
$15
Verity Pharmaceuticals Inc.
$15
Helsinn Therapeutics (U.S.), Inc.
$15
Acrotech Biopharma LLC
$14
AVEO Pharmaceuticals, Inc.
$14
AbbVie Inc.
$12
GE HEALTHCARE
$10
Top 3 companies account for 31.3% of all-time payments
Associated products mentioned in payments ›
ADAKVEO · ADCETRIS · AFINITOR · AKYNZEO · ALIMTA · ALUNBRIG · ANDEXXA · AUGTYRO · AYVAKIT · Afstyla · Alecensa · Aliqopa · Aranesp · Avastin · Axumin · BAVENCIO · BELEODAQ · BENDEKA · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · Blincyto · Braftovi · CABLIVI · CABOMETYX · CALQUENCE · CERDELGA · CEREZYME · CINVANTI · COPIKTRA · COSELA · CRIZANLIZUMAB · CYRAMZA · Cabometyx · Cinvanti · DARZALEX · DOPTELET · Doptelet · ELAHERE · ELITEK · ELREXFIO · EMPRINT · ENHERTU · ENJAYMO · ENTRESTO · ERLEADA · EXKIVITY · Elahere · Empaveli · Endari · Enhertu · Epkinly · Erleada · FARYDAK · FOTIVDA · FOUNDATIONACT · FOUNDATIONONE · FRUZAQLA · Fabhalta · GAZYVA · GILOTRIF · GIVLAARI · Herceptin · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INREBIC · Imbruvica · Itovebi · JAKAFI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · KRYSTEXXA · Kadcyla · Kyprolis · LIBTAYO · LONSURF · LOQTORZI · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · Lutathera · MAKO · MEKINIST · MEKTOVI · MONJUVI · MONOFERRIC · MVASI · MYLOTARG · Monoferric · NERLYNX · NINLARO · Nerlynx · Neulasta · Nplate · Nubeqa · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ODOMZO · ODOMZO (sonidegib) capsules · OJJAARA · ONIVYDE · OPDIVO · OPDUALAG · OXBRYTA · Odomzo · Onivyde · Optune · Optune Lua (NovoTTF-200T) · Orserdu · PADCEV · PANZYGA · PEMAZYRE · PIQRAY · PLUVICTO · POTELIGEO · PRADAXA · PROMACTA · PYRUKYND · Padcev · Pedmark · Perjeta · Phesgo · Polivy · Pomalyst · Poteligeo · Prolia · Quzyttir · REBLOZYL · RETEVMO · RYBREVANT · RYTELO · Revlimid · Rezlidhia · Rubraca · SANCUSO · SARCLISA · SCEMBLIX · SHINGRIX · SOLIRIS · SOMATULINE DEPOT · SUSTOL · SUTENT · SYLVANT · Somatuline Depot · Stivarga · TABRECTA · TAGRISSO · TASIGNA · TAXOTERE · TAZVERIK · TECENTRIQ · TECVAYLI · TEVIMBRA · TIBSOVO · TIVDAK · TUKYSA · Tavalisse · Tecentriq · Tibsovo · Trelstar · Trodelvy · UKONIQ · ULTOMIRIS · Udenyca · Ultomiris · VEGZELMA · VENCLEXTA · VERZENIO · VONJO · VOTRIENT · VYXEOS · Vectibix · Venclexta · Vitrakvi · Vonjo · XALKORI · XGEVA · XOSPATA · XPOVIO · XT CDX · XTANDI · Xermelo · Xofigo · Xospata · Xtandi · YONSA · Yescarta · ZEJULA · ZEPZELCA · ZOLADEX · Zoladex
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematology & oncology specialists in nearby ZIP areas
6
County median income
$58,535
Nearest hospital to ZIP centroid (approximate)
ADVENTHEALTH OCALA
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Balaraman is a mixed practice specialist, with above-average Medicare volume (top 3% in FL), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Balaraman experienced with darbepoetin injection (aranesp) for anemia?
Based on Medicare claims data, Dr. Balaraman performed 33,500 darbepoetin injection (aranesp) for anemia services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Balaraman receive payments from pharmaceutical companies?
Yes. Dr. Balaraman received a total of $95,697 from 105 companies across 1,217 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Balaraman's costs compare to other hematology & oncology specialists in Ocala?
Dr. Balaraman's average Medicare payment per service is $18. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Balaraman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Ocala
Browse hematology & oncology specialists in Ocala ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in FL
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in FL
Which FL hematology & oncology specialists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Genentech, Inc. Payments to Doctors
See all physicians who received payments from Genentech, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology